Taylor Herzog
Psychiatry · Dallas, TXNPI 1780065565
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 147 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,146 and has fallen 60.7% since, to $450 in 2025.
Across 147 payments — averaging $27.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$861
- Otsuka America Pharmaceutical, Inc.$837
- Validus Pharmaceuticals LLC$623
- Sunovion Pharmaceuticals Inc.$399
- Neurocrine Biosciences, Inc.$366
- Takeda Pharmaceuticals U.S.A., Inc.$131
- plus $878 from 18 others
What the payments were for
- Food & beverage$4,095100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 54 | $861 |
| Otsuka America Pharmaceutical, Inc. | 23 | $837 |
| Validus Pharmaceuticals LLC | 3 | $623 |
| Sunovion Pharmaceuticals Inc. | 5 | $399 |
| Neurocrine Biosciences, Inc. | 7 | $366 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $131 |
| Johnson & Johnson | 6 | $108 |
| Alkermes, Inc. | 5 | $96 |
| Merck | 7 | $93 |
| Shire North American Group Inc | 5 | $84 |
| Tris Pharma Inc | 3 | $69 |
| Avanir Pharmaceuticals, Inc. | 4 | $67 |
| Supernus Pharmaceuticals, Inc. | 3 | $67 |
| Almatica Pharma LLC | 2 | $62 |
| Lundbeck LLC | 3 | $49 |
| Eisai Inc. | 2 | $48 |
| Neos Therapeutics, LP | 2 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Harmony Biosciences LLC | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Livanova USA, Inc. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Aytu Biopharma, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,095 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.
Other psychiatry in Dallas
- Joel HolinerDallas$948K
- Augustus RushDallas$760K
- Darin OkudaDallas$402K
- Stephen VobachDallas$278K
- Carolyn RekerdresDallas$259K
- Madhukar TrivediDallas$209K
- Ella DalyDallas$67K
- Rakesh JainLake Jackson$7.2M
- Arvinder Pal WaliaAustin$2.5M
- Suresh SureddiPlano$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.